Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia

Published:2015-03 Issue:3 Volume:27 Page:409-425
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Geng Huimin,Hurtz Christian,Lenz Kyle B.,Chen Zhengshan,Baumjohann Dirk,Thompson Sarah,Goloviznina Natalya A.,Chen Wei-Yi,Huan Jianya,LaTocha Dorian,Ballabio Erica,Xiao Gang,Lee Jae-Woong,Deucher Anne,Qi Zhongxia,Park Eugene,Huang Chuanxin,Nahar Rahul,Kweon Soo-Mi,Shojaee Seyedmehdi,Chan Lai N.,Yu Jingwei,Kornblau Steven M.,Bijl Janetta J.,Ye B. Hilda,Mark Ansel K.,Paietta Elisabeth,Melnick Ari,Hunger Stephen P.,Kurre Peter,Tyner Jeffrey W.,Loh Mignon L.,Roeder Robert G.,Druker Brian J.,Burger Jan. A.,Milne Thomas A.,Chang Bill H.,Müschen Markus

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference45 articles.

1. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells;Bayly;J. Biol. Chem.,2004

2. Crosstalk between ROR1 and the pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia;Bicocca;Cancer Cell,2012

3. Haematological cancer: idelalisib—targeting PI3Kδ in patients with B-cell malignancies;Burger;Nat. Rev. Clin. Oncol.,2014

4. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia;Byrd;N. Engl. J. Med.,2013

5. Ibrutinib in relapsed chronic lymphocytic leukemia;Byrd;N. Engl. J. Med.,2013

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

2. Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia;Genome Biology;2024-05-31

3. Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL;Blood Advances;2024-05-31

4. Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4/PLC signaling;Nature Communications;2024-05-29

5. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03